Sorafenib

CAT: 400-SIH-476-50MGSize: 50 mgDry Ice: NoHazardous: No

50 mgSelected

PRICE

AVAILABILITY

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

1 / 2

Background

Sorafenib display inhibition of multiple kinase targets including, VEGFR, PDGFR, and Raf.

Description

Raf-1 kinase inhibitor

CAS Number

284461-73-0

Product Name Alternative

4-[4-[[4-chloro-3- (trifluoromethyl) phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzenesulfonic acid

UNSPSC

41116105

Type

Inhibitor

Source

Synthetic

Field of Research

Cell Signaling

Purity

>99%

Weight

0.05

Format

Off white powder

Solubility

Soluble inDMSO (200mg/ml) or ethanol (3mg/ml)

Molecular Formula

C21H16ClF3N4O3

Molecular Weight

464.8

Precautions

Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

References & Citations

1. Juan, L., et al. (2014) Environmental Toxic. Pharm. 38(2): 438–443.

Related Products

Catalog	Name